Parkinson Risk Assessment Out of Blood Samples

A new method for diagnosis and prognosis of Parkinson’s disease

Invention: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease affecting about 2% of the population over 65. The most prominent neuro¬patho¬logical characteristics of PD are progressive cell death within the nigrostriatal system and the appearance of cytoplasmatic aggregates of alpha-synuclein (SNCA), so-called Lewy bodies. The disease is typically diagnosed in an advanced stage when 70% of the dopaminergic neurons are lost. Especially in the light of new disease-modifying treat-ments, there is a great need for the early detection of PD. Scientists of the University of Bonn have found that the methylation pattern of the SNCA-gene is indicative for patients having developed PD. Surprisingly, it could be shown that said methylation status can be assessed based on DNA from peripheral blood cells.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors